These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27348860)

  • 1. Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Maggi G; Riva M; Masci G; D'Agostino G; Finocchiaro G; Santoro A; Bello L; Scorsetti M
    PLoS One; 2016; 11(6):e0157869. PubMed ID: 27348860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Maggi G; Rossi M; Riva M; Scorsetti M; Bello L
    World Neurosurg; 2016 Oct; 94():6-12. PubMed ID: 27373936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection.
    Navarria P; Pessina F; Cozzi L; Ascolese AM; De Rose F; Fogliata A; Franzese C; Franceschini D; Tozzi A; D'Agostino G; Comito T; Iftode C; Maggi G; Reggiori G; Bello L; Scorsetti M
    Radiat Oncol; 2016 Jun; 11():76. PubMed ID: 27249940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study.
    Navarria P; Pessina F; Clerici E; Franceschini D; Gay LG; De Rose F; Renna I; D'Agostino G; Franzese C; Comito T; Tomatis S; Nibali MC; Leonetti A; Puglisi G; Bello L; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1095-1105. PubMed ID: 31479701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
    Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
    Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
    Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
    Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting tumor control after resection bed radiosurgery of brain metastases.
    Luther N; Kondziolka D; Kano H; Mousavi SH; Engh JA; Niranjan A; Flickinger JC; Lunsford LD
    Neurosurgery; 2013 Dec; 73(6):1001-6; discussion 1006. PubMed ID: 24264235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
    Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
    Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen.
    Wang CC; Floyd SR; Chang CH; Warnke PC; Chio CC; Kasper EM; Mahadevan A; Wong ET; Chen CC
    J Neurooncol; 2012 Feb; 106(3):601-10. PubMed ID: 21879395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
    Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
    J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases.
    Bilger A; Milanovic D; Lorenz H; Oehlke O; Urbach H; Schmucker M; Weyerbrock A; Nieder C; Grosu AL
    Clin Neurol Neurosurg; 2016 Mar; 142():81-86. PubMed ID: 26816106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiotherapy for large solitary brain metastases.
    Feuvret L; Vinchon S; Martin V; Lamproglou I; Halley A; Calugaru V; Chea M; Valéry CA; Simon JM; Mazeron JJ
    Cancer Radiother; 2014 Mar; 18(2):97-106. PubMed ID: 24439342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFSRT of the resection cavity in patients with brain metastases.
    Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
    Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
    Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyberknife
    Telentschak S; Ruess D; Grau S; Goldbrunner R; von Spreckelsen N; Jablonska K; Treuer H; Kocher M; Ruge M
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2765-2773. PubMed ID: 33638006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer.
    Matsuyama T; Kogo K; Oya N
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):984-90. PubMed ID: 23092725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy.
    Pessina F; Navarria P; Tomatis S; Cozzi L; Franzese C; Di Guardo L; Ascolese AM; Reggiori G; Franceschini D; Del Vecchio M; Bello L; Scorsetti M
    World Neurosurg; 2017 Sep; 105():184-190. PubMed ID: 28578123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.